Shopping Cart
Remove All
Your shopping cart is currently empty
Suciraslimab
😃Good
Catalog No. T9901A-522Cas No. 2415439-63-1
Alias SM03, SM 03
Suciraslimab (SM03) is a human IgG1 monoclonal antibody against the B-cell restriction antigen CD22 for the treatment of rheumatoid arthritis (RA) and other B-cell related diseases.
Suciraslimab
Suciraslimab
😃Good
Catalog No. T9901A-522Alias SM03, SM 03Cas No. 2415439-63-1
Suciraslimab (SM03) is a human IgG1 monoclonal antibody against the B-cell restriction antigen CD22 for the treatment of rheumatoid arthritis (RA) and other B-cell related diseases.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $619 | - | In Stock | |
| 10 mg | $953 | - | In Stock | |
| 25 mg | $1,390 | - | In Stock | |
| 50 mg | $1,880 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:>95.0% (SDS-PAGE); 97.42% (SEC-HPLC)
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Suciraslimab (SM03) is a human IgG1 monoclonal antibody against the B-cell restriction antigen CD22 for the treatment of rheumatoid arthritis (RA) and other B-cell related diseases. |
| In vivo | In 5xFAD Alzheimer's disease mouse models, intraperitoneal injection of Suciraslimab (10 mg/kg, once weekly for 4 weeks) significantly enhanced microglial metabolic activity and phagocytosis, reduced brain amyloid plaque burden, and upregulated neuroprotective gene expression[1]. |
| Synonyms | SM03, SM 03 |
| Reactivity | Human |
| Verified Activity | Immobilized Human CD22-His at 2 μg/mL can bind Suciraslimab. The EC50 is 0.004412 μg/mL. |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | Siglec-2/CD22 |
| Molecular Weight | 146.16 kDa |
| Cas No. | 2415439-63-1 |
| Isotype | Human IgG1-REM kappa |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Suciraslimab | purchase Suciraslimab | Suciraslimab cost | order Suciraslimab | Suciraslimab in vivo | Suciraslimab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.